Received Mar 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | MG794 | PO / MO |
Patient given additional (3rd) dose of vaccine, which is not indicated. Also, patient falls outside of age parameters. No symptoms experienced at the time of vaccine or while observing after dose given. Manufacturer GSK contacted to report event on 3/6/26 with Rep Ref # 02541321.
None
None
Nose Drops 1%, as needed, acetaminophen 160 mg/5ml every 6 hours
None
None.